BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Actient, Columbia Laboratories sales and marketing update

Actient acquired U.S. rights to Columbia Laboratories' Striant testosterone buccal system for an undisclosed upfront cash payment. The mucoadhesive buccal tablets are approved for testosterone...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >